| SC 13G | 2013-02-13 | PRUDENTIAL FINANCIAL INC | Pacira Pharmaceuticals, Inc. | 2,179,095 | 6.7% | EDGAR |
| SC 13G/A | 2013-02-11 | PRICE T ROWE ASSOCIATES INC /MD/ | Pacira Pharmaceuticals, Inc. | 5,776,800 | 17.7% | EDGAR |
| SC 13G | 2013-02-11 | JENNISON ASSOCIATES LLC | Pacira Pharmaceuticals, Inc. | 2,176,700 | 6.7% | EDGAR |
| SC 13D/A | 2013-02-04 | Sanderling Venture Partners VI LP | Pacira Pharmaceuticals, Inc. | 920,755 | 2.8% | EDGAR |
| SC 13G/A | 2013-01-10 | GILDER GAGNON HOWE & CO LLC | Pacira Pharmaceuticals, Inc. | 3,932,011 | 12.1% | EDGAR |
| SC 13G | 2012-11-13 | GILDER GAGNON HOWE & CO LLC | Pacira Pharmaceuticals, Inc. | 3,586,671 | 11.0% | EDGAR |
| SC 13G/A | 2012-11-09 | PRICE T ROWE ASSOCIATES INC /MD/ | Pacira Pharmaceuticals, Inc. | 5,782,700 | 17.8% | EDGAR |
| SC 13D/A | 2012-09-28 | ORBIMED ADVISORS LLC | Pacira Pharmaceuticals, Inc. | 1,620,000 | 5.0% | EDGAR |
| SC 13D/A | 2012-06-15 | ORBIMED ADVISORS LLC | Pacira Pharmaceuticals, Inc. | 2,079,031 | 6.4% | EDGAR |
| SC 13G | 2012-04-20 | Visium Asset Management, LP | Pacira Pharmaceuticals, Inc. | 1,890,234 | 6.0% | EDGAR |
| SC 13D/A | 2012-03-19 | ORBIMED ADVISORS LLC | Pacira Pharmaceuticals, Inc. | 2,525,033 | 10.0% | EDGAR |
| SC 13G/A | 2012-02-14 | PRICE T ROWE ASSOCIATES INC /MD/ | Pacira Pharmaceuticals, Inc. | 3,098,450 | 12.7% | EDGAR |
| SC 13G | 2011-12-09 | PRICE T ROWE ASSOCIATES INC /MD/ | Pacira Pharmaceuticals, Inc. | 2,867,950 | 11.8% | EDGAR |
| SC 13D/A | 2011-12-01 | ORBIMED ADVISORS LLC | Pacira Pharmaceuticals, Inc. | 2,810,531 | 11.1% | EDGAR |
| SC 13D/A | 2011-12-01 | HBM BIOVENTURES CAYMAN LTD | Pacira Pharmaceuticals, Inc. | 3,524,322 | 13.9% | EDGAR |
| SC 13D/A | 2011-11-30 | Sanderling Venture Partners VI LP | Pacira Pharmaceuticals, Inc. | 1,420,755 | 5.6% | EDGAR |
| SC 13D/A | 2011-11-29 | MPM BioVentures IV QP LP | Pacira Pharmaceuticals, Inc. | 3,158,046 | 13.0% | EDGAR |
| SC 13D | 2011-02-18 | MPM BioVentures IV QP LP | Pacira Pharmaceuticals, Inc. | 2,725,472 | 15.8% | EDGAR |
| SC 13D | 2011-02-18 | HBM BIOVENTURES CAYMAN LTD | Pacira Pharmaceuticals, Inc. | 3,216,630 | 18.6% | EDGAR |
| SC 13D | 2011-02-18 | ORBIMED ADVISORS LLC | Pacira Pharmaceuticals, Inc. | 2,907,972 | 16.8% | EDGAR |